Effect of dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes of Taiwanese patients with treatment-naïve diabetic macular edema

JIA-KANG WANGHuang, Tzu-LunTzu-LunHuangChang, Pei-YaoPei-YaoChang2024-01-202024-01-202020-110929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/638669Vitrectomy may affect intravitreal drug clearance and efficacy for treating diabetic macular edema (DME). This study aimed to evaluate functional and anatomical outcomes of intravitreal dexamethasone (DEX) implant for vitrectomized and nonvitrectomized eyes with treatment-naïve DME in Taiwanese patients.enDexamethasone implant; Diabetic macular edema; Intravitreal injection; Vitrectomized[SDGs]SDG3Effect of dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes of Taiwanese patients with treatment-naïve diabetic macular edemajournal article10.1016/j.jfma.2020.04.014324826062-s2.0-85085606819https://api.elsevier.com/content/abstract/scopus_id/85085606819